Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (161-170 of 418) with videos related to

Pageof 42
Sort By:
Translational Lung Cancer Research|August 25, 2021
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and futureSijia Ren, Anyi Xu, Yilian Lin, et al.
Critical Reviews in Oncology/Hematology|December 17, 2013
Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trialsSara Pilotto, Massimo Di Maio, Umberto Peretti, et al.
Antimicrobial Resistance and Infection Control|April 10, 2019
Successful implementation of infection control measure in a neonatal intensive care unit to combat the spread of pathogenic multidrug resistant <i>Staphylococcus capitis</i>Jérôme Ory, Michel Cazaban, Brigitte Richaud-Morel, et al.
Endocrine-Related Cancer|May 5, 2021
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCCFabio Turco, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Journal of Cancer Policy|April 23, 2025
Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impactAnna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, et al.
Cells|March 10, 2022
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to BedsideAntonio Ungaro, Marcello Tucci, Alessandro Audisio, et al.
Palliative & Supportive Care|December 29, 2025
Implementation of psycho-existential symptom distress screening among Italian healthcare providersAndrea Bovero, Giorgia Feni, Laura Valenti, et al.
European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Breast Cancer Research and Treatment|August 6, 2002
p53 expression is decreased in primary breast carcinomas with microsatellite instabilityClaudia Pizzi, Luigi Panico, Laura De Marchis, et al.
Analytical Cellular Pathology (Amsterdam)|January 13, 2017
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based ChemotherapyErnesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, et al.
Pageof 42

Showing results (161-170 of 418) with videos related to

Sort By:
Pageof 42
Translational Lung Cancer Research|August 25, 2021
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and futureSijia Ren, Anyi Xu, Yilian Lin, et al.
Critical Reviews in Oncology/Hematology|December 17, 2013
Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trialsSara Pilotto, Massimo Di Maio, Umberto Peretti, et al.
Antimicrobial Resistance and Infection Control|April 10, 2019
Successful implementation of infection control measure in a neonatal intensive care unit to combat the spread of pathogenic multidrug resistant <i>Staphylococcus capitis</i>Jérôme Ory, Michel Cazaban, Brigitte Richaud-Morel, et al.
Endocrine-Related Cancer|May 5, 2021
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCCFabio Turco, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Journal of Cancer Policy|April 23, 2025
Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impactAnna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, et al.
Cells|March 10, 2022
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to BedsideAntonio Ungaro, Marcello Tucci, Alessandro Audisio, et al.
Palliative & Supportive Care|December 29, 2025
Implementation of psycho-existential symptom distress screening among Italian healthcare providersAndrea Bovero, Giorgia Feni, Laura Valenti, et al.
European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Breast Cancer Research and Treatment|August 6, 2002
p53 expression is decreased in primary breast carcinomas with microsatellite instabilityClaudia Pizzi, Luigi Panico, Laura De Marchis, et al.
Analytical Cellular Pathology (Amsterdam)|January 13, 2017
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based ChemotherapyErnesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, et al.
Pageof 42